Product
products

Our US Pharmaceuticals portfolio includes key marketed products, many of which are leaders in their respective therapeutic areas. Since 2000, our US division has received the most approvals of any pharmaceutical company in the industry.

Key pharmaceutical products marketed by Novartis in the US are listed below by therapeutic area, brand name and generic name.

Important Information:
Disease categories and product names are listed for your convenience in searching for and finding information about Novartis offerings. They are not intended to provide complete medical or product information. SHOULD YOU HAVE A MEDICAL CONDITION, PROMPTLY SEE YOUR OWN MEDICAL DOCTOR OR HEALTHCARE PROVIDER. Please see important safety information in the complete Prescribing Information, available by clicking on highlighted links near product names.

 

by generic name

 
 

aliskiren ( tablets ) 

prescribing information patient prescribing information
 

aliskiren and amlodipine ( tablets ) 

prescribing information patient prescribing information
 

aliskiren and hydrochlorothiazide ( tablets ) 

prescribing information patient prescribing information
 

aliskiren and valsartan, USP ( tablets ) 

prescribing information patient prescribing information
 

aliskiren, amlodipine and hydrochlorothiazide ( tablets ) 

prescribing information patient prescribing information
 

amlodipine and valsartan ( tablets ) 

prescribing information patient prescribing information
 

amlodipine besylate and benazepril hydrochloride combination capsule ( combination capsules ) 

prescribing information patient prescribing information
 

amlodipine, valsartan, hydrochlorothiozide ( tablets ) 

prescribing information patient prescribing information
 

artemether/lumefantrine ( tablets ) 

prescribing information
 

basiliximab ( for injection ) 

prescribing information
 

benazepril hydrochloride ( tablets ) 

prescribing information
 

benazepril hydrochloride and hydrochlorothiazide USP ( combination tablets ) 

prescribing information
 

bromocriptine mesylate ( tablets and capsules ) 

prescribing information
 

calcitonin-salmon ( nasal spray ) 

prescribing information patient prescribing information
 

calcitonin-salmon ( for injection ) 

prescribing information
 

canakinumab ( subcutaneous injection ) 

prescribing information patient prescribing information
 

carbamazepine ( extended-release tablets ) 

prescribing information
 

carbamazepine ( chewable tablets and suspension ) 

prescribing information
 

carbidopa, levodopa and entacapone ( tablets ) 

prescribing information
 

clozapine ( tablets ) 

prescribing information
 

cyclosporine ( injection ) 

prescribing information
 

cyclosporine ( oral solution, USP ) 

prescribing information
 

cyclosporine ( soft gelatin capsule, USP ) 

prescribing information
 

cyclosporine capsules, USP ( soft gelatin capsules ) 

prescribing information
 

cyclosporine oral solution, USP ( oral solution ) 

prescribing information
 

deferasirox ( tablets for oral suspension ) 

prescribing information
 

deferoxamine mesylate ( for injection, USP ) 

prescribing information
 

dexmethylphenidate hydrochloride ( extended-release capsules ) 

prescribing information medication guide
 

dexmethylphenidate hydrochloride ( tablets ) 

prescribing information medication guide
 

diclofenac potassium ( tablets ) 

prescribing information
 

diclofenac sodium ( extended-release tablets ) 

prescribing information
 

diclofenac sodium ( ophthalmic solution 0.1% ) 

prescribing information
 

entacapone ( tablets ) 

prescribing information
 

estradiol ( transdermal system ) 

prescribing information
 

estradiol ( transdermal system ) 

prescribing information
 

estradiol/norethindrone acetate ( transdermal system ) 

prescribing information
 

everolimus ( tablets ) 

prescribing information
 

everolimus ( tablets ) 

prescribing information medication guide
 

famciclovir ( tablets ) 

prescribing information
 

fingolimod ( capsules ) 

prescribing information medication guide
 

fluvastatin sodium ( extended-release tablets ) 

prescribing information patient prescribing information
 

fluvastatin sodium ( capsules ) 

prescribing information patient prescribing information
 

iloperidone ( tablets ) 

prescribing information
 

imatinib mesylate ( tablets ) 

prescribing information
 

indacaterol inhalation powder ( capsules ) 

prescribing information medication guide
 

interferon beta-1b ( injection ) 

prescribing information medication guide
 

letrozole ( tablets ) 

prescribing information
 

methylergonovine maleate ( tablets, USP ) 

prescribing information
 

methylergonovine maleate ( injection, USP ) 

prescribing information
 

methylphenidate hydrochloride ( sustained-release tablets, USP ) 

prescribing information medication guide
 

methylphenidate hydrochloride ( tablets, USP ) 

prescribing information medication guide
 

methylphenidate hydrochloride ( extended-release capsules ) 

prescribing information medication guide
 

metoprolol tartrate ( tablets and injection, USP ) 

prescribing information
 

metoprolol tartrate USP and hydrochlorothiazide USP ( tablets ) 

prescribing information
 

mycophenolic acid ( delayed-release tablets ) 

prescribing information medication guide
 

nateglinide ( tablets ) 

prescribing information
 

nilotinib ( capsules ) 

prescribing information medication guide
 

octreotide acetate ( injection ) 

prescribing information
 

octreotide acetate ( for injectable suspension ) 

prescribing information
 

omalizumab ( injection ) 

prescribing information
 

oxcarbazepine ( tablets and oral suspension ) 

prescribing information
 

pamidronate disodium ( for injection ) 

prescribing information
 

rivastigmine ( transdermal system ) 

prescribing information patient prescribing information
 

rivastigmine tartrate ( capsules and oral solution ) 

prescribing information
 

tacrolimus ( capsules ) 

prescribing information patient prescribing information
 

telbivudine ( tablets and oral solution ) 

prescribing information
 

terbinafine hydrochloride ( tablets ) 

prescribing information
 

terbinafine hydrochloride ( oral granules ) 

prescribing information
 

tobramycin ( solution for inhalation ) 

prescribing information patient prescribing information
 

valsartan ( tablets ) 

prescribing information patient prescribing information
 

valsartan and hydrochlorothiazide ( combination tablets ) 

prescribing information patient prescribing information
 

zoledronic acid ( Injection ) 

prescribing information patient prescribing information
 

zoledronic acid ( for injection ) 

prescribing information
 

 

Back to top

ACCESS TO MEDICINES


Novartis puts patients first. We want to create value for all patients, including those who cannot afford treatment. That is why we established Patient Assistance Now, a resource that allows you to access programs that may help you pay for your Novartis medicines.

PATIENT ASSISTANCE PROGRAMS

Through our Patient Assistance Programs, we are committed to providing access to our medications for those most in need.